X0306 4 2017-04-28 1 0001415336 Zeltiq Aesthetics Inc ZLTQ 0001547891 Garcia Sergio 4410 ROSEWOOD DRIVE PLEASANTON CA 94588 0 1 0 0 Senior VP, GC & Secretary Common Stock 2017-04-28 4 D 0 78415 D 0 D Stock Option (Right to Buy) 4.30 2017-04-28 4 D 0 32000 0.00 D 2022-11-15 Common Stock 32000 0 D Stock Option (Right to Buy) 20.88 2017-04-28 4 D 0 7500 0.00 D 2015-02-21 Common Stock 7500 0 D Stock Option (Right to Buy) 34.65 2017-04-28 4 D 0 3054 0.00 D 2025-02-18 Common Stock 3054 0 D Stock Option (Right to Buy) 23.03 2017-04-28 4 D 0 26702 0.00 D 2026-02-27 Common Stock 26702 0 D Stock Option (Right to Buy) 40.89 2017-04-28 4 D 0 16674 0.00 D 2027-01-17 Common Stock 16674 0 D Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc. a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer (the "Board"), whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger"). In connection with the Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all 78,415 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes. In connection with Merger, the Board accelerated and vested in full all equity awards held by the Reporting Person as of immediately prior to the closing of the Merger. Pursuant to the terms of the Merger Agreement, all shares subject to this option were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes. /s/ Sergio Garcia 2017-04-28